# Humulin R

NDC: 0002-0213
Generic name: Insulin human
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN OTC DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: PARENTERAL
Marketing started: 19830627
Marketing ended: 20261215
FDA application: BLA018780

## Active ingredients

- INSULIN HUMAN: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-0213"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-0213
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b519bd83-038c-4ec5-a231-a51ec5cc291f